Background and aims Attention deficit hyperactivity disorder (ADHD) and cerebral palsy (CP) are chronic diseases with major impact on quality of life (QoL) of children and their families. The goal of the study was to analyse the influence of pharmacologic treatment concerning the expression of satisfaction as key concept in the areas of life, compared to overall QoL and overall satisfaction on QoL.
Methods The scores assigned to the satisfaction in each area of life were statistically analysed with Wilcoxon test. For correlation analysis of the satisfaction in each area of life with overall QoL and overall satisfaction on QoL, non-parametric Spearman test was applied. Family Quality of Life Survey (FQOLS) - the version addressed to the main caregiver of the child with disability was used.
Results Wilcoxon statistic Z, applied to the comparison between the two time points of the scores for satisfaction in each area of life, resulted in associated statistical significance (p < 0.01) for all the areas for both CP and ADHD groups, for the difference between the two time points – before and after treatment.
Conclusions Pharmacologic treatment intervention influenced by a significant improvement the satisfaction in all area of life considered in this case after the disease being treated which is consistent with the hypothesis.
- Attention deficit hyperactivity disorder (ADHD)
- cerebral palsy (CP)
- Wilcoxon test
- Spearman test